BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: De Manzoni G, Marrelli D, Baiocchi GL, Morgagni P, Saragoni L, Degiuli M, Donini A, Fumagalli U, Mazzei MA, Pacelli F, Tomezzoli A, Berselli M, Catalano F, Di Leo A, Framarini M, Giacopuzzi S, Graziosi L, Marchet A, Marini M, Milandri C, Mura G, Orsenigo E, Quagliuolo V, Rausei S, Ricci R, Rosa F, Roviello G, Sansonetti A, Sgroi G, Tiberio GA, Verlato G, Vindigni C, Rosati R, Roviello F. The Italian Research Group for Gastric Cancer (GIRCG) guidelines for gastric cancer staging and treatment: 2015. Gastric Cancer 2017;20:20-30. [PMID: 27255288 DOI: 10.1007/s10120-016-0615-3] [Cited by in Crossref: 71] [Cited by in F6Publishing: 73] [Article Influence: 11.8] [Reference Citation Analysis]
Number Citing Articles
1 Pikuła A, Kwietniewska M, Rawicz-Pruszyński K, Ciseł B, Skórzewska M, Gęca K, Franciszkiewicz-Pietrzak K, Kurylcio A, Mielko J, Polkowski WP. The importance of Epstein-Barr virus infection in the systemic treatment of patients with gastric cancer. Semin Oncol 2020;47:127-37. [PMID: 32402473 DOI: 10.1053/j.seminoncol.2020.04.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
2 Ossola P, Mascioli F, Coletta D, Bononi M. Laparoscopic Mesogastrium Excision for Gastric Cancer: Only the Beginning. J Laparoendosc Adv Surg Tech A 2021;31:371-4. [PMID: 33052765 DOI: 10.1089/lap.2020.0743] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Morgagni P, Tringali D, La Barba G, Vittimberga G, Ercolani G. Historical assumptions of lymphadenectomy. Transl Gastroenterol Hepatol 2016;1:90. [PMID: 28138655 DOI: 10.21037/tgh.2016.11.06] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
4 Zhang Q, Zhang Q, Yan H, You Y, Cao J, Wang W, Zhao D, Zhang X, Wu J, Chen Z, Yang W. Survival Advantages in Gastric Cancer Patients Receiving Preoperative SOX Regimen Chemotherapy. Cancer Biother Radiopharm 2020. [PMID: 32833547 DOI: 10.1089/cbr.2020.3970] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Guo LQ, Chen Y, Teng XL, Xia WB, Xu J, Qu YK. TERT expression in gastric carcinogenesis: Correlation with clinical features. Shijie Huaren Xiaohua Zazhi 2018; 26(16): 979-985 [DOI: 10.11569/wcjd.v26.i16.979] [Reference Citation Analysis]
6 Graziosi L, Marino E, Bencivenga M, D'Ignazio A, Solaini L, Ministrini S, Caprioli M, Sacco M, Marrelli D, Mura G, Degiuli M, Morgagni P, Tiberio GAM, De Manzoni G, Roviello F, Donini A. Looking for a strategy in treating peritoneal gastric cancer carcinomatosis: an Italian multicenter Gastric Cancer Research group's analysis. World J Surg Oncol 2021;19:334. [PMID: 34819103 DOI: 10.1186/s12957-021-02442-9] [Reference Citation Analysis]
7 Barchi LC, Ramos MFKP, Dias AR, Andreollo NA, Weston AC, LourenÇo LG, Malheiros CA, Kassab P, Zilberstein B, Ferraz ÁAB, Charruf AZ, Brandalise A, Silva AMD, Alves B, Marins CAM, Leite CV, Bresciani CJC, Szor D, Mucerino DR; Consensus. II BRAZILIAN CONSENSUS ON GASTRIC CANCER BY THE BRAZILIAN GASTRIC CANCER ASSOCIATION. Arq Bras Cir Dig 2020;33:e1514. [PMID: 32844884 DOI: 10.1590/0102-672020190001e1514] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
8 Mazzei MA, Bagnacci G, Gentili F, Capitoni I, Mura G, Marrelli D, Petrioli R, Brunese L, Cappabianca S, Catarci M, Degiuli M, De Manzoni G, De Prizio M, Donini A, Romario UF, Funicelli L, Laghi A, Minetti G, Morgagni P, Petrella E, Pittiani F, Rausei S, Romanini L, Rosati R, Ianora AAS, Tiberio GAM, Volterrani L, Roviello F, Grassi R. Structured and shared CT radiological report of gastric cancer: a consensus proposal by the Italian Research Group for Gastric Cancer (GIRCG) and the Italian Society of Medical and Interventional Radiology (SIRM). Eur Radiol 2021. [PMID: 34383148 DOI: 10.1007/s00330-021-08205-0] [Reference Citation Analysis]
9 Baiocchi GL, Giacopuzzi S, Marrelli D, Reim D, Piessen G, Matos da Costa P, Reynolds JV, Meyer HJ, Morgagni P, Gockel I, Lara Santos L, Jensen LS, Murphy T, Preston SR, Ter-Ovanesov M, Fumagalli Romario U, Degiuli M, Kielan W, Mönig S, Kołodziejczyk P, Polkowski W, Hardwick R, Pera M, Johansson J, Schneider PM, de Steur WO, Gisbertz SS, Hartgrink H, van Sandick JW, Portolani N, Hölscher AH, Botticini M, Roviello F, Mariette C, Allum W, De Manzoni G. International consensus on a complications list after gastrectomy for cancer. Gastric Cancer 2019;22:172-89. [PMID: 29846827 DOI: 10.1007/s10120-018-0839-5] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 9.0] [Reference Citation Analysis]
10 Mazzei MA, Bagnacci G, Gentili F, Nigri A, Pelini V, Vindigni C, Mazzei FG, Baiocchi GL, Pittiani F, Morgagni P, Petrella E, Mura G, Verdelli B, Bencivenga M, Giacopuzzi S, Marrelli D, Roviello F, Volterrani L. Gastric Cancer Maximum Tumour Diameter Reduction Rate at CT Examination as a Radiological Index for Predicting Histopathological Regression after Neoadjuvant Treatment: A Multicentre GIRCG Study. Gastroenterol Res Pract 2018;2018:1794524. [PMID: 29736166 DOI: 10.1155/2018/1794524] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
11 Graziosi L, Marino E, Donini A. Reply to: "Impact of neoadjuvant therapy followed by laparoscopic radical gastrectomy with D2 lymph node dissection in Western population: a multi-institutional propensity score matched study". J Surg Oncol 2021. [PMID: 34709670 DOI: 10.1002/jso.26733] [Reference Citation Analysis]
12 Brisinda G, Chiarello MM, Crocco A, Adams NJ, Fransvea P, Vanella S. Postoperative mortality and morbidity after D2 lymphadenectomy for gastric cancer: A retrospective cohort study. World J Gastroenterol 2022;28:381-98. [PMID: 35110956 DOI: 10.3748/wjg.v28.i3.381] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Marrelli D, Ferrara F, Giacopuzzi S, Morgagni P, Di Leo A, De Franco L, Pedrazzani C, Saragoni L, De Manzoni G, Roviello F. Incidence and Prognostic Value of Metastases to "Posterior" and Para-aortic Lymph Nodes in Resectable Gastric Cancer. Ann Surg Oncol 2017;24:2273-80. [PMID: 28405772 DOI: 10.1245/s10434-017-5857-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
14 Roviello G, Corona SP, Multari AG, Petrioli R, Rosellini P, Aieta M. Poor outcome for patients with gastric cancer and lung metastases treated with ramucirumab and paclitaxel. Anti-Cancer Drugs 2019;30:745-8. [DOI: 10.1097/cad.0000000000000789] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
15 Lombardi PM, Mazzola M, Giani A, Baleri S, Maspero M, De Martini P, Gualtierotti M, Ferrari G. ERAS pathway for gastric cancer surgery: adherence, outcomes and prognostic factors for compliance in a Western centre. Updates Surg 2021. [PMID: 34018142 DOI: 10.1007/s13304-021-01093-5] [Reference Citation Analysis]
16 Stewart C, Chao J, Chen YJ, Lin J, Sullivan MJ, Melstrom L, Hyung WJ, Fong Y, Paz IB, Woo Y. Multimodality management of locally advanced gastric cancer-the timing and extent of surgery. Transl Gastroenterol Hepatol 2019;4:42. [PMID: 31231709 DOI: 10.21037/tgh.2019.05.02] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
17 Roviello G, Petrioli R, Rosellini P, Multari AG, Conca R, Paganini G, Chiriacò G, Aieta M. The influence of prior ramucirumab treatment on the clinical activity of FOLFIRI as third-line therapy in patients with metastatic gastric Cancer. Invest New Drugs 2019;37:524-30. [DOI: 10.1007/s10637-019-00725-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Mazzei MA, Nardone V, Di Giacomo L, Bagnacci G, Gentili F, Tini P, Marrelli D, Volterrani L. The role of delta radiomics in gastric cancer. Quant Imaging Med Surg 2018;8:719-21. [PMID: 30211038 DOI: 10.21037/qims.2018.07.08] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]
19 Baiocchi GL, Molfino S, Molteni B, Quarti L, Arcangeli G, Manenti S, Arru L, Botticini M, Gheza F. Fluorescence-guided lymphadenectomy in gastric cancer: a prospective western series. Updates Surg 2020;72:761-72. [PMID: 32607845 DOI: 10.1007/s13304-020-00836-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
20 Karavokyros I, Michalinos A. Favoring D2-Lymphadenectomy in Gastric Cancer. Front Surg 2018;5:42. [PMID: 29930941 DOI: 10.3389/fsurg.2018.00042] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
21 Koumarianou A, Krivan S, Machairas N, Ntavatzikos A, Pantazis N, Schizas D, Martikos G, Kampoli K, Misiakos EP, Patapis P, Liakakos T. Ten-year survival outcomes of patients with potentially resectable gastric cancer: impact of clinicopathologic and treatment-related risk factors. Ann Gastroenterol 2019;32:99-106. [PMID: 30598599 DOI: 10.20524/aog.2018.0320] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
22 Li J, Tan Y, Zhang D, Li J, Shen S, Jiang Y, Wu J. Value and necessity of pelvic CT in gastric cancer staging: an observational study. Scand J Gastroenterol 2018;53:1097-9. [PMID: 30270701 DOI: 10.1080/00365521.2018.1498121] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Morgagni P, Bencivenga M, Colciago E, Tringali D, Giacopuzzi S, Framarini M, Saragoni L, Mura G, Graziosi L, Marino E, Fumagalli Romario U, Baiocchi G, Moretti A, Rossi V, Verlato G. Limited Usefulness of 18F-FDG PET/CT in Predicting Tumor Regression After Preoperative Chemotherapy for Noncardia Gastric Cancer: The Italian Research Group for Gastric Cancer (GIRCG) Experience. Clin Nucl Med 2020;45:177-81. [PMID: 31977470 DOI: 10.1097/RLU.0000000000002911] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 da Costa PM, Lages P, Onofre S, Ribeiro RM. The impact of negative lymph nodes in the survival outcomes of pN+ patients following radical gastrectomy: the inverse lymph node ratio as a better score to study negative lymph nodes. Updates Surg 2020;72:1031-40. [PMID: 32388806 DOI: 10.1007/s13304-020-00757-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Yago A, Haruta S, Ueno M, Hamada Y, Ogawa Y, Ohkura Y, Urabe M, Udagawa H. Adequate period of surveillance in each stage for curatively resected gastric cancer: analyzing the time and rates of recurrence. Gastric Cancer 2021;24:752-61. [PMID: 33400037 DOI: 10.1007/s10120-020-01147-4] [Reference Citation Analysis]
26 Lombardi PM, Mazzola M, Achilli P, Aquilano MC, De Martini P, Curaba A, Gualtierotti M, Bertoglio CL, Magistro C, Ferrari G. Prognostic value of pathological tumor regression grade in locally advanced gastric cancer: New perspectives from a single-center experience. J Surg Oncol 2021;123:923-31. [PMID: 33497471 DOI: 10.1002/jso.26391] [Reference Citation Analysis]
27 Granieri S, Altomare M, Bruno F, Paleino S, Bonomi A, Germini A, Facciorusso A, Fagnani D, Bovo G, Cotsoglou C. Surgical treatment of gastric cancer liver metastases: Systematic review and meta-analysis of long-term outcomes and prognostic factors. Crit Rev Oncol Hematol 2021;163:103313. [PMID: 34044098 DOI: 10.1016/j.critrevonc.2021.103313] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Sheng Q, Zhang GD, Wen MY. Value of serum G-17, PGⅠ, PGⅡ, Hp-IgG in the screening of gastric cancer and precancerous lesions and its relationship with the depth of tumor invasion. Shijie Huaren Xiaohua Zazhi 2022; 30(5): 235-241 [DOI: 10.11569/wcjd.v30.i5.235] [Reference Citation Analysis]
29 Roviello G, Polom K, Roviello F, Marrelli D, Multari AG, Paganini G, Pacifico C, Generali D. Targeting VEGFR-2 in Metastatic Gastric Cancer: Results From a Literature-Based Meta-Analysis. Cancer Invest 2017;35:187-94. [PMID: 28165839 DOI: 10.1080/07357907.2016.1276185] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
30 Solaini L, Bazzocchi F, Pellegrini S, Avanzolini A, Perenze B, Curti R, Morgagni P, Ercolani G. Robotic vs open gastrectomy for gastric cancer: A propensity score-matched analysis on short- and long-term outcomes. Int J Med Robot 2019;15:e2019. [PMID: 31119901 DOI: 10.1002/rcs.2019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
31 Polom K, Böger C, Smyth E, Marrelli D, Behrens HM, Marano L, Becker T, Lordick F, Röcken C, Roviello F. Synchronous metastatic gastric cancer-molecular background and clinical implications with special attention to mismatch repair deficiency. Eur J Surg Oncol 2018;44:626-31. [PMID: 29545085 DOI: 10.1016/j.ejso.2018.02.208] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
32 Aytaç E, Aslan F, Çicek B, Erdamar S, Gürses B, Güven K, Falay O, Karahasanoğlu T, Selçukbiricik F, Selek U, Atalar B, Balık E, Tözün N, Rozanes İ, Arıcan A, Hamzaoğlu İ, Baca B, Molinas Mandel N, Saruç M, Göksel S, Demir G, Ağaoğlu F, Yakıcıer C, Özbek U, Özben V, Özyar E, Güner AL, Er Ö, Kaban K, Bölükbaşı Y, Buğra D, Group Tİ. Dealing with the gray zones in the management of gastric cancer: The consensus statement of the İstanbul Group. Turk J Gastroenterol 2019;30:584-98. [PMID: 30541724 DOI: 10.5152/tjg.2018.18737] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
33 Rim CH, Shin IS, Lee HY, Yoon WS, Park S. Oncologic Benefit of Adjuvant Chemoradiation after D2 Gastrectomy: A Stepwise Hierarchical Pooled Analysis and Systematic Review. Cancers (Basel) 2020;12:E2125. [PMID: 32751879 DOI: 10.3390/cancers12082125] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
34 Hu Q, He T, Sun Y, Wang F, Wu J. Effect of fast-track surgery on inflammatory response and immune function in patients with laparoscopic distal gastrectomy. Eur Surg 2019;51:254-60. [DOI: 10.1007/s10353-019-0572-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
35 Di Sibio A, Romano L, Giuliani A, Varrassi M, De Donato MC, Iacopino A, Perri M, Schietroma M, Carlei F, Di Cesare E, Masciocchi C. Nerve root metastasis of gastric adenocarcinoma: A case report and review of the literature. Int J Surg Case Rep. 2019;61:9-13. [PMID: 31302320 DOI: 10.1016/j.ijscr.2019.07.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
36 Bencivenga M, Verlato G, Mengardo V, Weindelmayer J, Allum WH. Do all the European surgeons perform the same D2? The need of D2 audit in Europe. Updates Surg 2018;70:189-95. [PMID: 29869322 DOI: 10.1007/s13304-018-0542-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
37 Marano L, Marrelli D, Sammartino P, Biacchi D, Graziosi L, Marino E, Coccolini F, Fugazzola P, Valle M, Federici O, Baratti D, Deraco M, Di Giorgio A, Macrì A, Pasqual EM, Framarini M, Vaira M, Roviello F; “Italian Peritoneal Surface Malignancies Oncoteam - S.I.C.O.”. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer with Synchronous Peritoneal Metastases: Multicenter Study of 'Italian Peritoneal Surface Malignancies Oncoteam-S.I.C.O.'. Ann Surg Oncol 2021. [PMID: 34057569 DOI: 10.1245/s10434-021-10157-0] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
38 Ruspi L, Galli F, Pappalardo V, Inversini D, Martignoni F, Boni L, Dionigi G, Rausei S. Lymphadenectomy in elderly/high risk patients: should it be different? Transl Gastroenterol Hepatol 2017;2:5. [PMID: 28217755 DOI: 10.21037/tgh.2016.12.07] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
39 Solaini L, Bencivenga M, Rosa F, D'ignazio A, Marino E, Ministrini S, Sofia S, Sacco M, Mura G, Rausa E, Prizio M, Graziosi L, Degiuli M, Tiberio GAM, Alfieri S, Marrelli D, Morgagni P, Ercolani G. Consequences of the COVID-19 pandemic on the diagnosis and treatment of gastric cancer in referral centers in Italy. Tumori 2022;:3008916211072586. [PMID: 35152794 DOI: 10.1177/03008916211072586] [Reference Citation Analysis]
40 Reddavid R, Sofia S, Chiaro P, Colli F, Trapani R, Esposito L, Solej M, Degiuli M. Neoadjuvant chemotherapy for gastric cancer. Is it a must or a fake? World J Gastroenterol 2018; 24(2): 274-289 [PMID: 29375213 DOI: 10.3748/wjg.v24.i2.274] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 26] [Article Influence: 9.5] [Reference Citation Analysis]
41 Liu F, Cao X, Ye J, Pan X, Kan X, Song Y. Oxaliplatin-induced hepatic sinusoidal obstruction syndrome in a patient with gastric cancer: A case report. Mol Clin Oncol. 2018;8:453-456. [PMID: 29468059 DOI: 10.3892/mco.2017.1540] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
42 Girnyi S, Ekman M, Marano L, Roviello F, Połom K. Complete Mesogastric Excisions Involving Anatomically Based Concepts and Embryological-Based Surgeries: Current Knowledge and Future Challenges. Curr Oncol 2021;28:4929-37. [PMID: 34898586 DOI: 10.3390/curroncol28060413] [Reference Citation Analysis]
43 Morgagni P, Solaini L, Saragoni L, Bencivenga M, Fumagalli Romario U, Graziosi L, Marino E, Marrelli D, Rausei S, Rosa F, Scarpi E, Tomezzoli A, Tringali D, Vindigni C, Vittimberga G, Roviello F; GIRCG. An aggressive early gastric cancer: Kodama's PenA type. Eur J Surg Oncol 2018;44:1186-90. [PMID: 29628438 DOI: 10.1016/j.ejso.2018.03.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
44 Shinohara H, Kurahashi Y, Ishida Y. Gastric equivalent of the 'Holy Plane' to standardize the surgical concept of stomach cancer to mesogastric excision: updating Jamieson and Dobson's historic schema. Gastric Cancer 2021;24:273-82. [PMID: 33387120 DOI: 10.1007/s10120-020-01142-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
45 Solaini L, Ministrini S, Bencivenga M, D'Ignazio A, Marino E, Cipollari C, Molteni B, Mura G, Marrelli D, Graziosi L, Roviello F, De Manzoni G, Tiberio GAM, Morgagni P. Conversion gastrectomy for stage IV unresectable gastric cancer: a GIRCG retrospective cohort study. Gastric Cancer. 2019;22:1285-1293. [PMID: 31065878 DOI: 10.1007/s10120-019-00968-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
46 Chen K, Pan Y, Zhang B, Maher H, Wang XF, Cai XJ. Robotic versus laparoscopic Gastrectomy for gastric cancer: a systematic review and updated meta-analysis. BMC Surg 2017;17:93. [PMID: 28836986 DOI: 10.1186/s12893-017-0290-2] [Cited by in Crossref: 53] [Cited by in F6Publishing: 44] [Article Influence: 10.6] [Reference Citation Analysis]
47 De Marco C, Biondi A, Ricci R. N staging: the role of the pathologist. Transl Gastroenterol Hepatol 2017;2:10. [PMID: 28275742 DOI: 10.21037/tgh.2017.01.02] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
48 Polom K, Marrelli D, Pascale V, Ferrara F, Voglino C, Marini M, Roviello F. The pattern of lymph node metastases in microsatellite unstable gastric cancer. Eur J Surg Oncol 2017;43:2341-8. [PMID: 28942235 DOI: 10.1016/j.ejso.2017.09.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
49 Yüksel A, Coşkun M, Turgut HT, Sümer F. Comparison of open and laparoscopic gastrectomy for gastric cancer: a low volume center experience. Turk J Surg 2021;37:33-40. [PMID: 34585092 DOI: 10.47717/turkjsurg.2021.5048] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
50 Giacopuzzi S, Bencivenga M, Cipollari C, Weindelmayer J, de Manzoni G. Lymphadenectomy: how to do it? Transl Gastroenterol Hepatol 2017;2:28. [PMID: 28447063 DOI: 10.21037/tgh.2017.03.09] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
51 Shin HJ, Choi YO, Roh CK, Son SY, Hur H, Han SU. ASO Author Reflections: Prediction of Survival Outcomes Based on Preoperative Clinical Parameters in Gastric Cancer. Ann Surg Oncol 2021. [PMID: 33682019 DOI: 10.1245/s10434-021-09785-3] [Reference Citation Analysis]
52 Solaini L, Bencivenga M, D'ignazio A, Milone M, Marino E, De Pascale S, Rosa F, Sacco M, Romario UF, Graziosi L, De Palma G, Marrelli D, Morgagni P, Ercolani G. Which gastric cancer patients could benefit from staging laparoscopy? A GIRCG multicenter cohort study. European Journal of Surgical Oncology 2022. [DOI: 10.1016/j.ejso.2022.01.020] [Reference Citation Analysis]
53 Tham E, Sestito M, Markovich B, Garland-Kledzik M. Current and future imaging modalities in gastric cancer. J Surg Oncol 2022;125:1123-34. [PMID: 35481912 DOI: 10.1002/jso.26875] [Reference Citation Analysis]
54 Roviello G, Petrioli R, Nardone V, Rosellini P, Multari AG, Conca R, Aieta M. Docetaxel, oxaliplatin, 5FU, and trastuzumab as first-line therapy in patients with human epidermal receptor 2-positive advanced gastric or gastroesophageal junction cancer: Preliminary results of a phase II study. Medicine (Baltimore) 2018;97:e10745. [PMID: 29768350 DOI: 10.1097/MD.0000000000010745] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
55 Zhou X, Yan DM, Zhu WF, Liu WJ, Nie HY, Xu S, Jiang YP, Zhang KH, Fu Y, Wan YY, Yu XY, Li H, Sun X, Chen XF. Efficacy and safety of Hou Gu Mi Xi in patients with spleen qi deficiency syndrome who underwent radical gastrectomy for gastric cancer: protocol for a multicenter, randomized, double-blind, placebo-controlled trial. Trials 2019;20:343. [PMID: 31182140 DOI: 10.1186/s13063-019-3429-x] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
56 Huang Z, Wei P. Compound Kushen Injection for gastric cancer: A protocol of systematic review and meta-analysis. Medicine (Baltimore) 2019;98:e17927. [PMID: 31702676 DOI: 10.1097/MD.0000000000017927] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
57 Roviello G, Corona SP, Multari AG, Paganini G, Chiriacò G, Conca R, Petrioli R, Generali D, Rosellini P, Aieta M. Association between ramucirumab-related hypertension and response to treatment in patients with metastatic gastric cancer. Oncotarget 2018;9:22332-9. [PMID: 29854281 DOI: 10.18632/oncotarget.24900] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
58 Machairas N, Charalampoudis P, Molmenti EP, Kykalos S, Tsaparas P, Stamopoulos P, Sotiropoulos GC. The value of staging laparoscopy in gastric cancer. Ann Gastroenterol 2017;30:287-94. [PMID: 28469358 DOI: 10.20524/aog.2017.0133] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
59 Baiocchi GL, Celotti A, Molfino S, Baggi P, Tarasconi A, Baronio G, Arru L, Gheza F, Tiberio G, Portolani N. Distant nodal metastasis: is it always an unresectable disease? Transl Gastroenterol Hepatol 2017;2:1. [PMID: 28217751 DOI: 10.21037/tgh.2016.12.01] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
60 Lorenzon L, Giudicissi R, Scatizzi M, Balducci G, Cantafio S, Biondi A, Persiani R, Mercantini P, D'Ugo D. D1-plus vs D2 nodal dissection in gastric cancer: a propensity score matched comparison and review of published literature. BMC Surg 2020;20:126. [PMID: 32522177 DOI: 10.1186/s12893-020-00714-x] [Reference Citation Analysis]
61 Sobhani N, Generali D, Roviello G. PAK6-Associated Support Vector Machine Classifier: A New Way to Evaluate Response and Survival of Gastric Cancer Treated by 5-FU/Oxaliplatin Chemotherapy. EBioMedicine 2017;22:18-9. [PMID: 28688823 DOI: 10.1016/j.ebiom.2017.07.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
62 Gianotti L, Fumagalli Romario U, De Pascale S, Weindelmayer J, Mengardo V, Sandini M, Cossu A, Parise P, Rosati R, Bencini L, Coratti A, Colombo G, Galli F, Rausei S, Casella F, Sansonetti A, Maggioni D, Costanzi A, Bernasconi DP, De Manzoni G. Association Between Compliance to an Enhanced Recovery Protocol and Outcome After Elective Surgery for Gastric Cancer. Results from a Western Population-Based Prospective Multicenter Study. World J Surg 2019;43:2490-8. [DOI: 10.1007/s00268-019-05068-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
63 Charruf AZ, Ramos MFKP, Pereira MA, Dias AR, de Castria TB, Zilberstein B, Cecconelo I, Ribeiro U. Impact of neoadjuvant chemotherapy on surgical and pathological results of gastric cancer patients: A case-control study. J Surg Oncol 2020;121:833-9. [PMID: 31943232 DOI: 10.1002/jso.25839] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
64 Xie ZY, Chai RM, Ding GC, Liu Y, Ren K. T and N Staging of Gastric Cancer Using Dual-Source Computed Tomography. Gastroenterol Res Pract 2018;2018:5015202. [PMID: 30622560 DOI: 10.1155/2018/5015202] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
65 Saragoni L, Scarpi E, Ravaioli A, Morgagni P, Roviello F, Vindigni C, Rausei S, Chiaravalli AM, Fumagalli U, Spaggiari P, Rosa F, Ricci R, Donini A, Giovenali P, Tomezzoli A, De Manzoni G. Early Gastric Cancer: Clinical Behavior and Treatment Options. Results of an Italian Multicenter Study on Behalf of the Italian Gastric Cancer Research Group (GIRCG). Oncologist 2018;23:852-8. [PMID: 29386311 DOI: 10.1634/theoncologist.2017-0488] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
66 Wang X, Sun J, Zhang W, Yang X, Zhu C, Pan B, Zeng Y, Xu J, Chen X, Shen X. Use of radiomics to extract splenic features to predict prognosis of patients with gastric cancer. Eur J Surg Oncol 2020;46:1932-40. [PMID: 32694053 DOI: 10.1016/j.ejso.2020.06.021] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
67 Bencivenga M, Torroni L, Verlato G, Mengardo V, Sacco M, Allum WH, de Manzoni G. Lymphadenectomy for gastric cancer at European specialist centres. Eur J Surg Oncol 2021;47:1048-54. [PMID: 33092970 DOI: 10.1016/j.ejso.2020.10.013] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
68 Saragoni L, Solaini L, Marrelli D, Ambrosio MR, Bencivenga M, Tomezzoli A, Milandri C, Terrinazzi V, Baiocchi GL, Baronchelli C, Foca F, Ercolani G, Morgagni P. Validating a nodal regression system for gastric cancer: An ancillary cohort study of the GASTRODOC trial. Int J Surg 2021;94:106112. [PMID: 34536601 DOI: 10.1016/j.ijsu.2021.106112] [Reference Citation Analysis]
69 Lombardi PM, Mazzola M, Nicastro V, Giacopuzzi S, Baiocchi GL, Castoro C, Rosati R, Fumagalli Romario U, Bonavina L, Staderini F, Gockel I, Gregori D, De Martini P, Gualtierotti M, Danieli M, Beretta S, Mutignani M, Forti E, Ferrari G. The iGreenGO Study: The Clinical Role of Indocyanine Green Imaging Fluorescence in Modifying the Surgeon’s Conduct During the Surgical Treatment of Advanced Gastric Cancer—Study Protocol for an International Multicenter Prospective Study. Front Oncol 2022;12:854754. [DOI: 10.3389/fonc.2022.854754] [Reference Citation Analysis]
70 Mazzei MA, Cioffi Squitieri N, Vindigni C, Guerrini S, Gentili F, Sadotti G, Mercuri P, Righi L, Lucii G, Mazzei FG, Marrelli D, Volterrani L. Gastrointestinal stromal tumors (GIST): a proposal of a "CT-based predictive model of Miettinen index" in predicting the risk of malignancy. Abdom Radiol (NY) 2020;45:2989-96. [PMID: 31506758 DOI: 10.1007/s00261-019-02209-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
71 Huang L, Zhang X, Wei Z, Xu A. Importance of Examined Lymph Node Number in Accurate Staging and Enhanced Survival in Resected Gastric Adenocarcinoma-The More, the Better? A Cohort Study of 8,696 Cases From the US and China, 2010-2016. Front Oncol 2020;10:539030. [PMID: 33585181 DOI: 10.3389/fonc.2020.539030] [Reference Citation Analysis]
72 Baiocchi GL, Giacopuzzi S, Reim D, Piessen G, Costa PMD, Reynolds JV, Meyer HJ, Morgagni P, Gockel I, Santos LL, Jensen LS, Murphy T, D'Ugo D, Rosati R, Fumagalli Romario U, Degiuli M, Kielan W, Mönig S, Kołodziejczyk P, Polkowski W, Pera M, Schneider PM, Wijnhoven B, de Steur WO, Gisbertz SS, Hartgrink H, van Sandick JW, Botticini M, Hölscher AH, Allum W, De Manzoni G. Incidence and Grading of Complications After Gastrectomy for Cancer Using the GASTRODATA Registry: A European Retrospective Observational Study. Ann Surg 2020;272:807-13. [PMID: 32925254 DOI: 10.1097/SLA.0000000000004341] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
73 Solaini L, D'Ignazio A, Marrelli D, Marano L, Avanzolini A, Morgagni P, Roviello F, Ercolani G. The effect of learning curve on perioperative outcomes of robotic gastrectomy in two western high-volume centers. Int J Med Robot 2021;17:e2212. [PMID: 33340239 DOI: 10.1002/rcs.2212] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
74 Feng C, Cheng J, Zeng X, Zhang Y, Hong N, Ye Y, Wang Y. Development and evaluation of a ceMDCT-based preoperative risk stratification model to predict disease-free survival after radical surgery in patients with gastric cancer. Abdom Radiol (NY) 2021;46:4079-89. [PMID: 33811513 DOI: 10.1007/s00261-021-03049-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
75 Lee JS, Lee JH, Kim J, Na HK, Ahn JY, Jung KW, Kim DH, Choi KD, Song HJ, Lee GH, Jung HY. Predictive Role of Endoscopic Surveillance after Total Gastrectomy with R0 Resection for Gastric Cancer. J Korean Med Sci 2021;36:e88. [PMID: 33847079 DOI: 10.3346/jkms.2021.36.e88] [Reference Citation Analysis]
76 Marrelli D, De Franco L, Iudici L, Polom K, Roviello F. Lymphadenectomy: state of the art. Transl Gastroenterol Hepatol 2017;2:3. [PMID: 28217753 DOI: 10.21037/tgh.2017.01.01] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
77 Marrelli D, Polom K, Neri A, Roviello F. Clinical impact of molecular classifications in gastric cancer. Updates Surg 2018;70:225-32. [PMID: 29796937 DOI: 10.1007/s13304-018-0546-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
78 Bencivenga M, Palla I, Scorsone L, Bortolami A, Mengardo V, Pavarana M, Turchetti G, de Manzoni G. Clinical pathways in gastric cancer care. Updates Surg 2018;70:279-91. [PMID: 29923079 DOI: 10.1007/s13304-018-0544-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
79 Zeng X, Yang SW, Yang HQ, Chen Y, Pan QJ. Effect of bifid triple viable combined with enteral nutrition support on gastrointestinal function and nutritional indexes in patients with gastric cancer after operation. Shijie Huaren Xiaohua Zazhi 2020; 28(11): 410-416 [DOI: 10.11569/wcjd.v28.i11.410] [Reference Citation Analysis]
80 de Manzoni G, Yang HK. Gastric cancer surgery. Updates Surg 2018;70:155. [PMID: 29948661 DOI: 10.1007/s13304-018-0551-3] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
81 Weindelmayer J, Mengardo V, Gasparini A, Sacco M, Torroni L, Carlini M, Verlato G, de Manzoni G. Enhanced Recovery After Surgery can Improve Patient Outcomes and Reduce Hospital Cost of Gastrectomy for Cancer in the West: A Propensity-Score-Based Analysis. Ann Surg Oncol 2021. [PMID: 33988796 DOI: 10.1245/s10434-021-10079-x] [Reference Citation Analysis]
82 Ikari N, Serizawa A, Mitani S, Yamamoto M, Furukawa T. Near-Comprehensive Resequencing of Cancer-Associated Genes in Surgically Resected Metastatic Liver Tumors of Gastric Cancer. The American Journal of Pathology 2019;189:784-96. [DOI: 10.1016/j.ajpath.2018.12.015] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
83 Aurello P, Petrucciani N, Antolino L, Giulitti D, D'Angelo F, Ramacciato G. Follow-up after curative resection for gastric cancer: Is it time to tailor it? World J Gastroenterol 2017; 23(19): 3379-3387 [PMID: 28596674 DOI: 10.3748/wjg.v23.i19.3379] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
84 Mazzei MA, Di Giacomo L, Bagnacci G, Nardone V, Gentili F, Lucii G, Tini P, Marrelli D, Morgagni P, Mura G, Baiocchi GL, Pittiani F, Volterrani L, Roviello F. Delta-radiomics and response to neoadjuvant treatment in locally advanced gastric cancer-a multicenter study of GIRCG (Italian Research Group for Gastric Cancer). Quant Imaging Med Surg 2021;11:2376-87. [PMID: 34079708 DOI: 10.21037/qims-20-683] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
85 Ekman M, Girnyi S, Marano L, Roviello F, Chand M, Diana M, Polom K. Near-Infrared Fluorescence Image-Guided Surgery in Esophageal and Gastric Cancer Operations. Surg Innov. [DOI: 10.1177/15533506211073417] [Reference Citation Analysis]
86 Monti M, Morgagni P, Nanni O, Framarini M, Saragoni L, Marrelli D, Roviello F, Petrioli R, Fumagalli Romario U, Rimassa L, Bozzarelli S, Donini A, Graziosi L, De Angelis V, De Manzoni G, Bencivenga M, Mengardo V, Parma E, Milandri C, Mura G, Signorini A, Baiocchi G, Molfino S, Sgroi G, Steccanella F, Rausei S, Proserpio I, Viganò J, Brugnatelli S, Rinnovati A, Santi S, Ercolani G, Foca F, Valmorri L, Amadori D, Frassineti GL. Preoperative or Perioperative Docetaxel, Oxaliplatin, and Capecitabine (GASTRODOC Regimen) in Patients with Locally-Advanced Resectable Gastric Cancer: A Randomized Phase-II Trial. Cancers (Basel) 2020;12:E2790. [PMID: 33003302 DOI: 10.3390/cancers12102790] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
87 De Franco L, Marrelli D, Voglino C, Vindigni C, Ferrara F, Di Mare G, Iudici L, Marini M, Roviello F. Prognostic Value of Perineural Invasion in Resected Gastric Cancer Patients According to Lauren Histotype. Pathol Oncol Res 2018;24:393-400. [PMID: 28555306 DOI: 10.1007/s12253-017-0257-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
88 Zheng XH, Zhang W, Yang L, Du CX, Li N, Xing GS, Tian YT, Xie YB. Role of D2 gastrectomy in gastric cancer with clinical para-aortic lymph node metastasis. World J Gastroenterol 2019; 25(19): 2338-2353 [PMID: 31148905 DOI: 10.3748/wjg.v25.i19.2338] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
89 Rosati R, Parise P, Giannone Codiglione F. Technical pro & cons of the laparoscopic lymphadenectomy. Transl Gastroenterol Hepatol 2016;1:93. [PMID: 28138658 DOI: 10.21037/tgh.2016.12.04] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
90 Morgagni P, Solaini L, Framarini M, Vittimberga G, Gardini A, Tringali D, Valgiusti M, Monti M, Ercolani G. Conversion surgery for gastric cancer: A cohort study from a western center. Int J Surg 2018;53:360-5. [PMID: 29654967 DOI: 10.1016/j.ijsu.2018.04.016] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]